A Multi-center Study of hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse Post Definitive Surgery and Standard Therapy
Latest Information Update: 07 Aug 2020
At a glance
- Drugs INO 1400 (Primary) ; INO 9012 (Primary)
- Indications Breast cancer; Carcinoma; Colorectal cancer; Gastric cancer; Head and neck cancer; Liver cancer; Lung cancer; Oesophageal cancer; Ovarian cancer; Pancreatic cancer
- Focus Adverse reactions
- Sponsors Inovio Pharmaceuticals
- 15 Nov 2018 Status changed from active, no longer recruiting to completed.
- 08 May 2018 Planned End Date changed from 1 Dec 2018 to 1 Nov 2018.
- 08 May 2018 Planned primary completion date changed from 1 Dec 2018 to 1 Nov 2018.